WorthPointe LLC grew its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 77.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 469 shares of the company’s stock after acquiring an additional 204 shares during the period. […]

Glenmede Trust Co. NA trimmed its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 1.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,296 shares of the company’s stock after selling 5,297 shares during the quarter. […]

Cadence Bank cut its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,811 shares of the company’s stock after selling 1,117 shares during the period. Cadence Bank’s holdings in […]